Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from multi-disciplinary teams for milestone-driven research projects that utilize novel, structure-based vaccine design approaches to generate candidate vaccine immunogens against infectious disease pathogens of clinical concern.


  • Letter of Intent Due Date(s): September 3, 2016
  • Application Due Date(s): October 3, 2016

​RFA-AI-16-047 Expiration Date October 4, 2016

Agency Website

Amount Description

Budgets for direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in the first year of the award for major equipment to ensure that research objectives can be met and biohazards can be contained, totaling $1,050,000 direct costs.

The scope of the proposed project should determine the project period. The maximum project period is 5 years.   

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 3, 2016